申请人:A/S Ferrosan
公开号:US04845095A1
公开(公告)日:1989-07-04
Piperidine compounds having the formula ##STR1## wherein R.sup.1 is hydrogen, (C.sub.1-6 -alkoxyaryl)alkyl, diphenylmethozy-C.sub.1-6 -alkyl, C.sub.1-8 -alkyl, C.sub.4-10 -cycloalkylalkyl, phenoxy-C.sub.1-8 -alkyl, or C.sub.1-6 -alkoxy-C.sub.1-6 -alkyl; and R is ##STR2## or CH.dbd.NOR' wherein R' is C.sub.1-6 -alkyl, C.sub.3-7 -cycloalkyl, C.sub.1-6 -alkoxy-C.sub.1-6 -alkyl, aryl-C.sub.0-6 -alkyl, which may optionally be substituted with one or more halogen and (.sub.1-5 -alkoxy, thienyl, or C.sub.4-7 -cycloalkylalkyl. The novel compounds are useful for the treatment of pain conditions and as neuroleptics.
含有以下结构的哌啶化合物:其中R.sup.1是氢,(C.sub.1-6 -烷氧基芳基)烷基,二苯甲氧基-C.sub.1-6 -烷基,C.sub.1-8 -烷基,C.sub.4-10 -环烷基烷基,苯氧基-C.sub.1-8 -烷基,或C.sub.1-6 -烷氧基-C.sub.1-6 -烷基;而R是##STR2##或CH.dbd.NOR',其中R'是C.sub.1-6 -烷基,C.sub.3-7 -环烷基,C.sub.1-6 -烷氧基-C.sub.1-6 -烷基,芳基-C.sub.0-6 -烷基,可以选择地用一个或多个卤素和(.sub.1-5 -烷氧基,噻吩基,或C.sub.4-7 -环烷基烷基替代。这些新化合物可用于治疗疼痛症状和作为神经精神药。